A Randomized Open Label Phase II Trial Comparing BIBW2992 Plus Simvastatin With BIBW2992 Plus Best Supportive Care in Previously Treated Patients With Advanced (Stage IIIB/IV) Non-adenocarcinomatous Non-small Cell Lung Cancer (NSCLC).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Aug 2017
At a glance
- Drugs Afatinib; Simvastatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 24 Aug 2017 Planned End Date changed from 1 Dec 2015 to 1 Dec 2017.
- 24 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated